Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: Pediatr Crit Care Med. 2017 Mar;18(3 Suppl 1):S32–S45. doi: 10.1097/PCC.0000000000001052

Figure 3.

Figure 3

Phenotype specific therapies reported as effective in resolving inflammation and facilitating MODS recovery.

HLA - Human leukocyte antigen; TNF – Tumor necrosis factor; LPS – Lipopolysaccharide; TAMOF - Thrombocytopenia associated multiple organ failure; Plt Ct – Platelet count; AKI – Acute kidney injury; DIC – Disseminated intravascular coagulation; SMOF – Sequential multiple organ failure; IVIG- Intravenous immunoglobulin; PTLD - Post-transplant lymphoproliferative disorder; HLH - Hemophagocytic lymphohistiocytosis; sFASL - Soluble Fas ligand; IRAP - Interleukin-1 (IL-1) receptor antagonist protein